{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:07:52Z","timestamp":1759838872389,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["project number 13\/17\/04"],"award-info":[{"award-number":["project number 13\/17\/04"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0142-5","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T20:36:26Z","timestamp":1490042186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual"],"prefix":"10.1186","volume":"14","author":[{"given":"Gail","family":"Gilchrist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davina","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Keding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Towers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Craine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"issue":"1","key":"142_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-181","volume":"13","author":"SJ Hahn\u00e9","year":"2013","unstructured":"Hahn\u00e9 SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, van de Laar M. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13(1):1.","journal-title":"BMC Infect Dis"},{"issue":"9651","key":"142_CR2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet"},{"key":"142_CR3","volume-title":"Unlinked anonymous monitoring survey of people who inject drugs: data tables","author":"Public Health England, National Infection Service","year":"2015","unstructured":"Public Health England, National Infection Service. Unlinked anonymous monitoring survey of people who inject drugs: data tables. London: Public Health England; 2015."},{"key":"142_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jvh.12117","volume":"21","author":"N Palmateer","year":"2014","unstructured":"Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21:25\u201332. http:\/\/dx.doi.org\/10.1111\/jvh.12117 .","journal-title":"J Viral Hepat"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2013.05.014","volume":"133","author":"S Corson","year":"2013","unstructured":"Corson S, Greenhalgh D, Taylor A, Palmateer N, Goldberg D, Hutchinson S. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. Drug Alcohol Depend. 2013;133:172\u20139. http:\/\/dx.doi.org\/10.1016\/j.drugalcdep.2013.05.014 .","journal-title":"Drug Alcohol Depend"},{"issue":"Supplement 3","key":"142_CR6","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1086\/651479","volume":"50","author":"RM Grant","year":"2010","unstructured":"Grant RM. Antiretroviral agents used by HIV-uninfected persons for prevention: pre-and postexposure prophylaxis. Clin Infect Dis. 2010;50(Supplement 3):S96\u2013101.","journal-title":"Clin Infect Dis"},{"key":"142_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-med-050911-163701","volume":"64","author":"J Baeten","year":"2013","unstructured":"Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annu Rev Med. 2013;64:219.","journal-title":"Annu Rev Med"},{"issue":"suppl 2","key":"142_CR8","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","volume":"57","author":"EJ Aspinall","year":"2013","unstructured":"Aspinall EJ, Corson S, Doyle JS, Grebely J, Hutchinson SJ, Dore GJ, Goldberg DJ, Hellard ME. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 2013;57 suppl 2:S80\u20139.","journal-title":"Clin Infect Dis"},{"key":"142_CR9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KM Turner","year":"2011","unstructured":"Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106:1978\u201388.","journal-title":"Addiction"},{"key":"142_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","volume":"376","author":"L Degenhardt","year":"2010","unstructured":"Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285\u2013301.","journal-title":"Lancet"},{"key":"142_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25:34\u201352.","journal-title":"Int J Drug Policy"},{"key":"142_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235\u201348.","journal-title":"Int J Epidemiol"},{"key":"142_CR13","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.addbeh.2008.07.005","volume":"33","author":"S O\u2019Brien","year":"2008","unstructured":"O\u2019Brien S, Day C, Black E, Dolan K. Injecting drug users\u2019 understanding of hepatitis C. Addict Behav. 2008;33:1602\u20135. http:\/\/dx.doi.org\/ 10.1016\/j.addbeh.2008.07.005 .","journal-title":"Addict Behav"},{"key":"142_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10826080902864894","volume":"45","author":"R Cohen-Moreno","year":"2010","unstructured":"Cohen-Moreno R, Schiff M, Levitt S, Bar-Hamburger R, Strauss S, Neumark Y. Knowledge about hepatitis C among methadone maintenance treatment patients in Israel. Subst Use Misuse. 2010;45:58\u201376.","journal-title":"Subst Use Misuse"},{"key":"142_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2010.11.018","volume":"116","author":"C Treloar","year":"2011","unstructured":"Treloar C, Hull P, Bryant J, Hopwood M, Grebely J, Lavis Y. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Drug Alcohol Depend. 2011;116:52\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"142_CR16","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s10461-011-9991-1","volume":"15","author":"G Gilchrist","year":"2011","unstructured":"Gilchrist G, Blazquez A, Torrens M. Psychiatric, behavioural and social risk factors in HIV infection among female drug users. AIDS Behav. 2011;15:1834\u201343. http:\/\/dx.doi.org\/10.1007\/s10461-011-9991-1 .","journal-title":"AIDS Behav"},{"key":"142_CR17","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","volume":"161","author":"SA Strathdee","year":"2001","unstructured":"Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281\u20138.","journal-title":"Arch Intern Med"},{"key":"142_CR18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2015.04.017","volume":"152","author":"G Gilchrist","year":"2015","unstructured":"Gilchrist G, Singleton N, Donmall M, Jones A. Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England. Drug Alcohol Depend. 2015;152:116\u201322.","journal-title":"Drug Alcohol Depend"},{"key":"142_CR19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.nmd.0000230396.17230.28","volume":"194","author":"E Disney","year":"2006","unstructured":"Disney E, Kidorf M, Kolodner K, King V, Peirce J, Beilenson P, et al. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. J Nerv Ment Dis. 2006;194:577\u201383.","journal-title":"J Nerv Ment Dis"},{"key":"142_CR20","unstructured":"Public Health England, Health Protection Scotland, Public Health Wales, and Public Health Agency Northern Ireland. Shooting up: infections among people who inject drugs in the United Kingdom 2015. An update November 2016. London, Public Health England. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/567231\/Shooting_Up_2016_Update.pdf . Accessed 30 Jan 2017."},{"key":"142_CR21","doi-asserted-by":"crossref","unstructured":"Hope VD, Cullen KJ, Smith J, Jessop L, Parry J, Ncube F. Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection? Euro Surveill. 2016;21(19).","DOI":"10.2807\/1560-7917.ES.2016.21.19.30225"},{"key":"142_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","volume":"204","author":"H Hagan","year":"2011","unstructured":"Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204:74\u201383.","journal-title":"J Infect Dis"},{"key":"142_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007192.pub2","volume":"1","author":"N Meader","year":"2010","unstructured":"Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010;1, CD007192. http:\/\/dx.doi.org\/ 10.1002\/14651858.CD007192.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"key":"142_CR24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugpo.2011.08.002","volume":"23","author":"R Sacks-Davis","year":"2012","unstructured":"Sacks-Davis R, Horyniak D, Grebely J, Hellard M. Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review. Int J Drug Policy. 2012;23:176\u201384.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 2","key":"142_CR25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/QAI.0b013e31815767c4","volume":"46","author":"DW Purcell","year":"2007","unstructured":"Purcell DW, Latka MH, Metsch LR, Latkin CA, G\u00f3mez CA, Mizuno Y, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46 Suppl 2:S35\u201347.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"142_CR26","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s10461-011-0079-8","volume":"16","author":"P Vazan","year":"2012","unstructured":"Vazan P, Mateu-Gelabert P, Cleland CM, Sandoval M, Friedman SR. Correlates of staying safe behaviors among long-term injection drug users: psychometric evaluation of the staying safe questionnaire. AIDS Behav. 2012;16:1472\u201381.","journal-title":"AIDS Behav"},{"key":"142_CR27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1521\/aeap.14.2.172.23902","volume":"14","author":"MP Carey","year":"2002","unstructured":"Carey MP, Schroder KE. Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. AIDS Educ Prev. 2002;14:172\u201382.","journal-title":"AIDS Educ Prev"},{"key":"142_CR28","doi-asserted-by":"crossref","unstructured":"Gilchrist G, Taylor A, Fischer G, Moskalewicz J. Di Furia L, K\u00f6chl B, Giammarchi C, D\u0105browska K, Shaw A, Munro A, Torrens M. Feasibility of a psychosocial group intervention to reduce hepatitis C risk behaviours and increase transmissionknowledge among females who inject drugs in 5 European cities. Drugs, Education, Prevention and Policy. 2017;24(2):179\u201388. http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09687637.2016.1197885 .","DOI":"10.1080\/09687637.2016.1197885"},{"key":"142_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1471-6712.2008.00668.x","volume":"23","author":"L Balfour","year":"2009","unstructured":"Balfour L, Kowal J, Corace KM, Tasca GA, Krysanski V, Cooper CL, et al. Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale. Scand J Caring Sci. 2009;23:801\u20138.","journal-title":"Scand J Caring Sci"},{"key":"142_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/1753-6405.12378","volume":"39","author":"B Hajarizadeh","year":"2015","unstructured":"Hajarizadeh B, Wallace J, Richmond J, Ngo N, Enright C. Hepatitis B knowledge and associated factors among people with chronic hepatitis B. Aust N Z J Public Health. 2015;39:563\u20138.","journal-title":"Aust N Z J Public Health"},{"key":"142_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337\u201343.","journal-title":"Ann Med"},{"key":"142_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clinl Pract. 2004;10:307\u201312.","journal-title":"J Eval Clinl Pract"},{"key":"142_CR33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391.","journal-title":"Pharm Stat"},{"key":"142_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2288-10-67","volume":"10","author":"M Arain","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.","journal-title":"BMC Med Res Methodol"},{"key":"142_CR35","volume-title":"Drug misuse: psychosocial interventions","author":"National Institute for Health and Clinical Excellence","year":"2007","unstructured":"National Institute for Health and Clinical Excellence. Drug misuse: psychosocial interventions. London: National Institute for Health and Clinical Excellence; 2007."},{"issue":"5","key":"142_CR36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B Hout Van","year":"2012","unstructured":"Van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315.","journal-title":"Value Health"},{"key":"142_CR37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/pubmed\/fdp131","volume":"32","author":"N Craine","year":"2010","unstructured":"Craine N, Hickman M, Parry JV, Smith J, McDonald T, Lyons M. Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. J Public Health. 2010;32:328\u201335.","journal-title":"J Public Health"},{"key":"142_CR38","volume-title":"Women in substance abuse treatment: results from the alcohol and drug services study (ADSS). Vol. Analytic Series A-26","author":"TM Brady","year":"2005","unstructured":"Brady TM, Ashley OS. Women in substance abuse treatment: results from the alcohol and drug services study (ADSS). Vol. Analytic Series A-26. Rockville: Substance Abuse and Mental Health Services Administration, Office of Applied Studies: DHHS Pub. No. SMA 04\u20133968; 2005."},{"key":"142_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/713659321","volume":"19","author":"B Powis","year":"2000","unstructured":"Powis B, et al. Drug-using mothers: social, psychological and substance use problems of women opiate users with children. Drug Alcohol Rev. 2000;19:171\u201380.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"142_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-120018838","volume":"29","author":"OS Ashley","year":"2003","unstructured":"Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29(1):19\u201353.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"142_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(03)00159-4","volume":"26","author":"SK Avants","year":"2004","unstructured":"Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004;26(2):67\u201378.","journal-title":"J Subst Abuse Treat"},{"key":"142_CR42","doi-asserted-by":"crossref","unstructured":"Garfein RS, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, \u2026 & DUIT Study Team., A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. Aids. 2007;21(14):1923\u2013132.","DOI":"10.1097\/QAD.0b013e32823f9066"},{"issue":"5","key":"142_CR43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2105\/AJPH.2007.113415","volume":"98","author":"MH Latka","year":"2008","unstructured":"Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health. 2008;98(5):853\u201361.","journal-title":"Am J Public Health"},{"issue":"2","key":"142_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1037\/0278-6133.22.2.223","volume":"22","author":"A Margolin","year":"2003","unstructured":"Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22(2):223\u20138.","journal-title":"Health Psychol"},{"issue":"1","key":"142_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10461-010-9751-7","volume":"15","author":"RE Booth","year":"2011","unstructured":"Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson CJ, Choi D, Robinson J, Calsyn DA, Mandler RN, Jenkins LM, Thompson LL, Dempsey CL, Liepman MR, McCarty D. Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav. 2011;15(1):30\u201344.","journal-title":"AIDS Behav"},{"issue":"1","key":"142_CR46","first-page":"55","volume":"29","author":"CA Green","year":"2006","unstructured":"Green CA. Gender and use of substance abuse treatment services. Alcohol Res Health. 2006;29(1):55\u201362.","journal-title":"Alcohol Res Health"},{"issue":"6","key":"142_CR47","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","volume":"107","author":"M Harris","year":"2012","unstructured":"Harris M, Rhodes T. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction. 2012;107(6):1090\u20136.","journal-title":"Addiction"},{"key":"142_CR48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1049732311420579","volume":"22","author":"M Harris","year":"2012","unstructured":"Harris M, Treloar C, Maher L. Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res. 2012;22:31\u201342.","journal-title":"Qual Health Res"},{"key":"142_CR49","doi-asserted-by":"crossref","unstructured":"Mateu-Gelabert P, Gwadz MV, Guarino H, Sandoval M, Cleland CM, Jordan A, \u2026 & Friedman SR. The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. AIDS Educ Prev. 2014;26(2):144.","DOI":"10.1521\/aeap.2014.26.2.144"},{"key":"142_CR50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2015.06.032","volume":"154","author":"H Valerio","year":"2015","unstructured":"Valerio H, Goldberg DJ, Lewsey J, Weir A, Allen S, Aspinall EJ, Barclay ST, Bramley P, Dillon JF, Fox R, Fraser A, Hayes PC, Innes H, Kennedy N, Mills PR, Stanley AJ, Hutchinson SJ. Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: implications for reinfection. Drug Alcohol Depend. 2015;154:125\u201331.","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0142-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T20:41:15Z","timestamp":1568925675000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0142-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0142-5","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"article-number":"14"}}